Algorhythm Holdings (RIME) - Due Diligence

hourglass

Loading…

Preparing the latest DD data, styles and content.

30RiskyDD: Aug 26, 2026Analyst: 27

paidPrice at analysis date

USD 0.29 (26/08/2026)

domainMkt cap

$4.95M

pie_chartShares

16.99M

candlestick_chart52W

$0.28-$4.58

trending_downShort interest

3.5%

HIGHNASDAQ Capital MarketInformation Technology49 employeesFounded 1982

Verdict: Caution

Distressed nano-cap (~$5M market cap) with explicit going-concern risk, active Nasdaq minimum-bid breach notice (cure deadline 2026-12-14), negative margins and extreme dilution. Q2 2026 showed real SemiCab traction: revenue $3.0M, +25% sequentially and +161% YoY, plus P&G India contract expansion and Onida MSA. But cash/restricted cash of ~$8.0M sits against ~$8.7M notes, current liabilities exceed current assets, a July 2026 settlement can issue up to 5.0M shares, and common equity remains a binary claim on financing survival.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 — updated 2026-08-26

Algorhythm Holdings (RIME)

AI-enabled freight logistics platform (SemiCab) · NASDAQ Capital Market · Fort Lauderdale

"Real SemiCab growth inside a financing-dependent, dilution-heavy public shell."

Going concern Nasdaq delisting risk Altman Z −7.18 Q2 revenue +161% YoY Settlement dilution

Fin. strength

/20 pts

EBITDA/FCF

/15 pts

Debt/leverage

/15 pts

Stage/business

/15 pts

Catalysts

/10 pts

Reg. risk

/8 pts

Risk/reward

/7 pts

Management

/5 pts

Sector/macro

/3 pts

Compliance

/2 pts

💡 Fair Value Estimate — SotP (probability-weighted, going-concern adjusted)

Fair value base case

USD 0.34

Range: USD 0.00-USD 1.20

Price at analysis date: USD 0.29 (26/08/2026)

Base upside/downside: +17%

Distressed EV/Revenue SotP. The 0.8x core multiple is derived from low-margin freight/logistics peers at ~0.4–0.7x sales, then nudged upward for Q2 growth and AI/SaaS optionality, but discounted through explicit dilution and liability reserves rather than a generic multiple haircut. Analyst consensus is N/D, so there is no target-price reconciliation. The base FV is only +17% above the latest close and is not robust: one financing tranche can change the per-share math materially. ⚠️ Not investment advice.

Component	Assumption	USD/share
SemiCab India core platform	$11.5M FY26E revenue run-rate × 0.8x distressed EV/Sales = $9.2M EV / 16.99M shares	+0.54
SemiCab Apex SaaS option	25% probability × $10.0M option NPV for first US SaaS contracts / 16.99M shares	+0.15
Cash and restricted cash	$8.0M cash + restricted cash at 2026-06-30 / 16.99M current shares	+0.47
Notes, related-party debt and leases	($6.4M promissory notes + $2.3M related-party notes + $0.3M leases) / 16.99M shares	−0.53
CCI settlement reserve	$1.928M claim × 120% recovery cap = $2.31M expected share-settlement value / 16.99M shares	−0.14
Dilution reserve	30% haircut × $0.49 pre-dilution value from rows above, reflecting 5.0M settlement-share capacity and active financing need	−0.15
FV base case	Sum of rows above (0.54 + 0.15 + 0.47 − 0.53 − 0.14 − 0.15)	≈ $0.34

Bull

$0.70–1.20

Probability: 20%

SemiCab keeps >20% sequential revenue growth, gross loss narrows materially, Apex signs first named US customers and Nasdaq compliance is cured without another highly dilutive structure.

Base

$0.25–0.45

Probability: 45%

Muddle-through: Q2 growth continues but negative gross margin and working-capital pressure force more shares. The company survives, but per-share value is capped by financing terms.

Bear

$0.00–0.10

Probability: 35%

Nasdaq issue is not cured, dilution accelerates and noteholders or settlement counterparties absorb most of the remaining enterprise value. Common equity has little residual claim.

Methodology: Distressed EV/Revenue SotP. The 0.8x core multiple is derived from low-margin freight/logistics peers at ~0.4–0.7x sales, then nudged upward for Q2 growth and AI/SaaS optionality, but discounted through explicit dilution and liability reserves rather than a generic multiple haircut. Analyst consensus is N/D, so there is no target-price reconciliation. The base FV is only +17% above the latest close and is not robust: one financing tranche can change the per-share math materially. ⚠️ Not investment advice. Not investment advice.

warning

🚨 Going concern flag + Nasdaq delisting notice — Critical

(1) RIME remains a going-concern / financing-risk situation: operations are loss-making and the company depends on external capital while scaling SemiCab. (2) Nasdaq compliance notice was received after 30 consecutive business days below the $1.00 minimum bid; cure window closes 2026-12-14 and requires a close at or above $1.00 for at least 10 consecutive business days. (3) The company already completed a 1:200 reverse split on 2025-02-10 and may need another corporate action or a large price-moving event. (4) July 2026 liability settlement authorizes up to 5.0M shares until the counterparty receives 120% of a $1.928M claim, adding direct dilution pressure.

⚠️ Methodology note: RIME is a sub-$5M nano-cap in active financial distress with a recent business pivot. Standard DCF is not reliable because the operating model is still loss-making and the share count is unstable. Valuation is built as a risk-adjusted sum-of-parts: SemiCab revenue multiple + cash/restricted cash − notes/leases − liability-settlement reserve − dilution haircut. Analyst consensus is N/D; public market data currently shows no usable analyst price target.

📊 Capital Structure · Short Interest · Buyback & Dilution

🟢 Short Interest

3.5%

592,526 shares short, equal to ~3.5% of float/outstanding, with 2.76 days-to-cover. Low reported short interest does not remove dilution risk; the bigger overhang is primary issuance.

🔴 Share dilution (1Y)

+709%

Shares outstanding rose to 16.99M, +708.93% YoY and +53.05% QoQ. The July 2026 CCI settlement can add up to 5.0M more shares, capped at 19.99% ownership at any time.

🔴 Buyback

No buyback program and no dividend. Capital is consumed by operating burn, notes, settlement shares and SemiCab commercialization. StockAnalysis shows shareholder yield deeply negative.

Short Interest — context

RIME — 3.5%

3.5%

Short interest is not the thesis driver. The main capital-structure signal is dilution: 16.99M shares outstanding versus 3.41M at year-end 2025, a $1.928M liability settlement payable through shares, and no evidence of material insider selling above $500K in the last 12 months; recent Form 4 items are primarily grants or non-cash changes.

$Financial analysis — TTM + FY guidance

Revenue TTM

$8.52M

Q2 revenue $3.0M, +161% YoY

Gross margin TTM

−26.3%

Q2 improved 850 bps sequentially

Cash & equivalents

$8.0M

cash + restricted cash at Jun 30

FCF TTM

−$15.0M

TTM net loss; no FCF anchor

Item	FY2023	FY2024	FY2025	TTM / H1'26	Guidance 2026E
Revenue ($M)	~7.0 legacy	0.30	4.39	8.52 TTM / 5.41 H1	~11–13 run-rate based
Gross margin (%)	n/d	~−65	−29.9	−26.3 TTM	still negative, improving
Operating loss ($M)	~−8.3	−8.44	−7.95	−12.72 TTM	loss-making
Net loss ($M)	−9.38	−23.26	−15.87	−15.03 TTM / −8.94 H1	loss-making
Cash + restricted cash ($M)	6.7	7.23	6.15	7.96 at Jun 30	requires discipline
Shares outstanding (M)	~0.35	~2.39	3.41	16.99 current	likely higher with settlement

Note: FY2023 still included legacy karaoke economics, while FY2025 and H1 2026 reflect the SemiCab pivot. Management has not provided formal EBITDA guidance; run-rate estimates are derived from Q1 revenue of $2.4M and Q2 revenue of $3.0M.

Quarterly dynamics — last 5 quarters (continuing operations)
Metric	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue ($M)	1.15	~1.7	~1.4	2.40	3.01
Gross margin (%)	n/d	~−20	~−25	negative	negative, +850 bps QoQ
Net loss ($M)	−0.59	~−5.8	~−5.2	−5.11	−3.83
End-of-period cash ($M)	n/d	~10.9	6.15	10.9	7.96

Financial position and sustainability

Q2 sequential revenue growth

+25%

Current assets / current liabilities

0.90x

Share dilution YoY

+709%

Altman Z-Score (bankruptcy risk)

−7.18

account_tree

Business model — From karaoke to AI freight platform

Algorhythm in one slide

Algorhythm Holdings is the renamed parent of the legacy Singing Machine karaoke business that pivoted to AI logistics in 2025. The surviving operating asset is SemiCab, an AI-enabled freight orchestration platform that matches loads to truck capacity using real-time data, TMS/ELD integrations and predictive optimization. Q2 2026 revenue reached $3.0M, up 25% sequentially and 161% YoY, with P&G India contract expansion, a new Onida Electronics MSA and continued Apex SaaS commercialization in North America. The strategic narrative is real, but the public equity shell is fragile: margins remain negative, the share count is exploding and Nasdaq compliance is unresolved.

SemiCab India (managed services + SaaS) ~$10–12M FY26E (95%+ rev) 🟢 ramping Live in India with FMCG and electronics customers. Q2 added a P&G India contract expansion and Onida Electronics MSA. The managed-service layer drives revenue, but gross margin is still negative; SaaS mix must rise to prove unit economics. SemiCab US SaaS rollout ~$0–2M FY26E (early) 🟡 to be proven Apex is being commercialized in North America with Jonathan Miller hired as VP of U.S. Sales. No material named U.S. revenue disclosure yet. This is the main upside option, but it requires sales capital that RIME may struggle to fund. Legacy / discontinued $0 (sold Aug 2025) 🔴 wound down Singing Machine karaoke sold to Stingray for $4.5M. Eliminated ~$4M liabilities and ~70% of annual cash outflow but also the only revenue line with positive history. RIME now 100% bet on SemiCab.

gavel

Legal, regulatory and risk analysis

Going concern flag (10-Q Q1 2026)

Critical

Auditor-style language: substantial doubt about ability to continue as a going concern. Cash $7.7M vs ~$10–12M annual burn = sub-1-year runway. Without fresh equity issuance, equity holders face full impairment risk within 12 months.

Nasdaq delisting (minimum-bid)

Critical

Notice received covering May 4 – June 15, 2026 (30 sessions below $1.00). Cure deadline 2026-12-14. Already used the 1:200 reverse split tool in Feb 2025 — Nasdaq increasingly hostile to repeat splitters. Delisting to OTC means liquidity collapse and institutional sell-side mandates.

Dilution (Streeterville / S-1 effective)

Critical

Shares Out +708.93% YoY, +242.56% QoQ. Active S-1/A registers Streeterville as selling stockholder. Every operating quarter has been funded by new issuance — pattern continues until business turns FCF positive (no near-term path).

Negative gross margin

High

GM −29.78% TTM: COGS structurally above revenue in India managed-services model. Profitability requires either price increase (unlikely with FMCG anchor customers) or asset-light SaaS shift (US opportunity, but unproven). No clear path to GM positive within 18 months.

Net debt position (−$0.28/sh)

High

$11.8M total debt vs $7.7M cash = net debt $4.1M. Debt/Equity 3.72x. Streeterville-type notes typically carry conversion features that increase equity dilution if not repaid in cash. Debt is senior to equity in any restructuring.

SemiCab ARR ramp + marquee customers

Positive

$12M+ ARR (April 2026) with P&G, Coca-Cola, Unilever, MTR Foods, Onida as live customers. 5,716 loads Q1'26. Revenue +1,851% YoY (low base, but directionally real). FMCG anchor customers provide commercial validation, not survival guarantee.

India FX + execution risk

High

Most revenue is INR-denominated, reported in USD. Indian truck-broker market is fragmented and price-competitive. SemiCab competes with local players (Rivigo, BlackBuck, Porter) plus large diversified logistics. No proprietary moat beyond software differentiation.

Strategic-buyer optionality

Positive

SemiCab platform with FMCG anchor customers and India footprint is plausibly attractive to large logistics players (CHRW, XPO, Uber Freight, Indian conglomerates). Stocktwits retail chatter +4,150% (June 2026) speculates buyout. No formal process disclosed. Asymmetric upside if a deal materializes.

article

SWOT analysis

Strengths

+SemiCab ARR $12M+ with marquee FMCG customers (P&G, Coca-Cola, Unilever)
+Karaoke divestiture (Aug 2025) cleaned the balance sheet and eliminated ~70% of cash outflow
+India freight market is large and digitizing; SemiCab has operational footprint
+Strategic-buyer optionality is real (logistics roll-ups, FMCG-aligned acquirers)

Weaknesses

−Going concern flag in Q1 2026 10-Q — equity holders carry impairment risk
−Negative gross margin (−30% TTM): unit economics unproven at scale
−Dilution +709% YoY; capital structure designed around continuous issuance
−Altman Z −7.18 and Piotroski 4 = quantitative distress signature
−Nasdaq listing in active jeopardy (cure deadline Dec 14, 2026)

Opportunities

→India digital freight TAM growing >20%/yr; SemiCab inside the wave
→US SaaS rollout could lift gross margin if scaled (asset-light model)
→M&A optionality with sub-$5M market cap — strategic discount possible
→If SemiCab revenue keeps compounding and gross loss narrows, equity story improves materially

Threats

!Nasdaq delisting to OTC removes institutional buyers and crushes liquidity
!Convoy / Loadsmart-style failure pattern: AI freight rarely makes asset-light economics work
!Streeterville-style note structures increasingly punitive if not retired in cash
!Indian competitors (BlackBuck, Rivigo IPO ramp) with deeper local capital

article

Summary by assessment area

🔴 Financial risk — Critical

Going concern flag + net debt position
Cash runway <12 months at current burn
Altman Z −7.18 = quantitative distress

🔴 Compliance risk — Critical

Nasdaq minimum-bid breach; cure by 2026-12-14
Reverse split tool already used (1:200, Feb 2025)
OTC fallback removes institutional bid

🟡 R/R — Binary lottery

No genuine floor (negative net cash)
Bear case is OTC / accelerated dilution
Bull case requires gross-margin proof + Nasdaq cure

2026-09-30 capital_markets

CCI settlement share issuance window

short-term Impact: High Direction: Bearish

The July 2026 settlement allows up to 5.0M shares until CCI receives 120% of a $1.928M claim. Any issuance pace update is directly relevant to per-share value.

2026-12-14 regulatory

Nasdaq $1.00 minimum-bid cure deadline

medium-term Impact: High Direction: Binary

Need ≥$1.00 close for 10 consecutive sessions before this date. Otherwise, Nasdaq begins delisting process to OTC. Likely tools: another reverse split, a strategic announcement spike, or appeal/extension. Single most important date on the calendar.

2026-09-30 product

SemiCab US SaaS broader rollout (announced 2H 2026)

short-term Impact: Medium Direction: Bullish

Management guided "broader US rollout during 2026". First named US customer or pilot would shift narrative from "India-only" to "global AI logistics platform" and could expand strategic-buyer interest.

2026-11-13 earnings

Q3 2026 earnings — pre-Nasdaq-deadline status

medium-term Impact: High Direction: Binary

Last earnings print before Nasdaq deadline. SemiCab ARR target ≥$14–15M, gross margin trend, runway disclosure, any commentary on strategic alternatives. Material price-moving event in either direction.

2026-10-31 capital_markets

Likely capital raise or second reverse split (proxy date)

short-term Impact: High Direction: Bearish

Cash runway forces a financing event within 2026. Either further Streeterville-type tranches (dilutive) or another reverse split to satisfy Nasdaq (mechanical short-term price rise but cosmetic). Both negative for sustained equity value.

2027-03-31 ma

Strategic transaction window (SemiCab acquisition or asset sale)

long-term Impact: High Direction: Bullish

Only meaningful path to bull-case valuation. Logistics roll-ups (XPO, CHRW), FMCG-aligned acquirers, Indian conglomerates, or private-equity could acquire SemiCab platform/team. Proxy date = end of 1Q27. Probability ~15% in base case.

{ "verdict_label": {"it": "Giudizio: Cautela", "en": "Verdict: Caution"}, "verdict_text": {"it": "RIME e' una nano-cap distressed con rischio Nasdaq, diluizione +709% YoY e settlement azionario. Q2 revenue +161% YoY, ma il bilancio non si autosostiene.", "en": "RIME is a distressed nano-cap with Nasdaq risk, +709% YoY dilution and an equity settlement overhang. Q2 revenue grew 161% YoY, but the balance sheet cannot self-fund."}, "bull_points": [ {"it": "Q2 revenue $3.0M: +25% sequenziale e +161% YoY, con P&G India e Onida come validazione commerciale", "en": "Q2 revenue reached $3.0M: +25% sequentially and +161% YoY, with P&G India and Onida validating demand"}, {"it": "Apex SaaS in Nord America resta l'opzione upside se arrivano clienti nominativi", "en": "Apex SaaS in North America remains the upside option if named customers arrive"}, {"it": "Cash + restricted cash circa $8.0M al 30 giugno 2026", "en": "Cash plus restricted cash was about $8.0M at June 30, 2026"} ], "bear_points": [ {"it": "Altman Z -7.18 e margine lordo TTM -26.3% segnalano distress quantitativo", "en": "Altman Z -7.18 and TTM gross margin of -26.3% signal quantitative distress"}, {"it": "Diluzione +709% YoY e settlement CCI fino a 5.0M azioni", "en": "+709% YoY dilution and CCI settlement capacity up to 5.0M shares"}, {"it": "Nasdaq cure entro 2026-12-14; reverse split gia' usato a febbraio 2025", "en": "Nasdaq cure deadline is 2026-12-14; reverse split tool was already used in February 2025"} ], "risks": [ {"it": "Bear case: OTC o diluizione accelerata lasciano valore residuo minimo all'equity comune", "en": "Bear case: OTC move or accelerated dilution leaves minimal residual value for common equity"}, {"it": "Unit economics non provate: Q2 mostra ancora gross loss nonostante crescita revenue", "en": "Unit economics remain unproven: Q2 still showed gross loss despite revenue growth"}, {"it": "Current liabilities superano current assets: pressione su capitale circolante e finanziamenti", "en": "Current liabilities exceed current assets, keeping pressure on working capital and financing"} ] }

Sources & Disclaimer

Sources: Algorhythm Q2 2026 results release and quarterly financial tables (2026-08-14), FY2025 10-K / results release, Nasdaq minimum-bid 8-K dated 2026-06-18, SemiCab promissory-note forbearance 8-K dated 2026-06-22, CCI liability-settlement 8-K dated 2026-07-24, StockAnalysis market/statistics data, Investing.com historical-price data, and MarketBeat / ChartMill short-interest and insider-filing summaries. Market data as of the latest verified close on 2026-08-26: RIME USD 0.291, market cap ~$4.95M, enterprise value ~$9.57M, shares outstanding 16.99M, 52W range $0.28-$4.58. Short interest: 592,526 shares, ~3.5% of float/outstanding and 2.76 days-to-cover. Analyst consensus: N/D. This document is for informational purposes only and does not constitute financial or investment advice.